Biggest News Aggregation in the World
📰 Endpoint Analysis News

Endpoint Analysis News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Endpoint Analysis. Real-time updates on events, politics, business and more.

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label...
Czech Republic United States Parag Mahanti David Soergel Prnewswire Novartis Marianne Silkj

Novartis Pharma AG: Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs.
United States Sloan Simpson Nicole Zinsli Somm Lambers Heerspink Jonathan Graham Satoshi Sugimoto

Novartis Pharma AG: Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical meeting2
United States Czech Republic Imke Kappes Marlena Abdinoor David Soergel Michael Meo

Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting

SEATTLE, Dec. 05, 2023 -- Adaptive Biotechnologies Corporation , a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to...
United States San Diego Karina Calzadilla Susan Bobulsky Erica Jones Idecabtagene Vicleucel

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Treace Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the ...

PONTE VEDRA, Fla., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical
United States Triplanar Tarsometatarsal Arthrodesis Julie Dewey Johnt Treace Robert Santrock American Orthopaedic Foot Ankle Society

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science